Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases

Trends in Cardiovascular Medicine

Volumn 12, Issue 8, 2002, Pages 331-338

  Olson, Steven T ^a   Chuang, Yung Jen ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; HEPARIN; PLASMA PROTEIN; PROCOAGULANT; PROTEINASE; THROMBIN;

ANTICOAGULATION; BLOOD CLOTTING; DRUG STRUCTURE; ENZYME BINDING; HEMOSTASIS; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SHORT SURVEY;

EID: 0036872229     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(02)00183-4     Document Type: Review

References (40)

1. Backovic M., Gettins P.G.W. Insight into residues critical for antithrombin function from an expanded database of sequences that includes frog, turtle and ostrich antithrombins. J Proteome Res. 1:2002;367-373.
2. Baugh R.J., Dickinson C.D., Ruf W., Krishnaswamy S. Exosite interactions determine the affinity of factor X for the extrinsic Xase complex. J Biol Chem. 275:2000;28,826-28,833.
3. Björk I., Olson S.T. Antithrombin. A bloody important serpin. Church F.C., Cunningham D.D., Ginsburg D.et al. Chemistry and Biology of Serpins. 1997;Plenum Press, New York., p 17.
4. Brandstetter H., Kuhne A., Bode W.et al. X-ray structure of active site-inhibited clotting factor Xa. J Biol Chem. 271:1996;29,988-29,992.
5. Choay J., Petitou M., Lormeau J.C.et al. Structure-activity relationship in heparin. a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity Biochem Biophys Res Commun. 116:1983;492-499.
6. Chuang Y.J., Gettins P.G.W., Olson S.T. Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly→Pro mutation. J Biol Chem. 274:1999;28,142-28,149.
7. Chuang Y.J., Swanson R., Raja S.M.et al. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Biochemistry. 40:2001;6670-6679. a.
8. Chuang Y.J., Swanson R., Raja S.M., Olson S.T. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. J Biol Chem. 276:2001;14,961-14,971. b.
9. Danielsson Å, Raub E., Lindahl U., Björk I. Role of ternary complexes in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem. 261:1986;15,467-15,473.
10. Djie M., Stone S., Le Bonniec B. Intrinsic specificity of the reactive site loop of antitrypsin, antichymotrypsin, antithrombin III, and protease nexin I. J Biol Chem. 272:1997;16,268-16,273.
11. Futamura A., Beecham J., Gettins P.G.W. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements. consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes Biochemistry. 40:2001;6680-6687.
12. Futamura A., Gettins P.G.W. Serine 380 (P14)→glutamate mutation activates antithrombin as an inhibitor of factor Xa. J Biol Chem. 275:2000;4092-4098.
13. Gettins P.G.W., Fan B., Crews B.C.et al. Transmission of conformational change from the heparin binding site to the reactive center of antithrombin. Biochemistry. 32:1993;8385-8389.
14. Gettins P.G.W., Patston P.A., Olson S.T. Serpins. Structure, Function and Biology:1996;R. G. Landes, Austin, TX.
15. Hermans J.M., Stone S.R. Interaction of activated protein C with serpins. Biochem J. 295:1993;239-245.
16. Hopkins P.C.R., Crowther D.C., Carrell R.W., Stone S.R. Development of a novel recombinant serpin with potential antithrombotic properties. J Biol Chem. 270:1995;11,866-11,871.
17. Hopkins P.C.R., Pike R.N., Stone S.R. Evolution of serpin specificity. cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C J Mol Evol. 51:2000;507-515.
18. Huntington J.A., McCoy A., Belzar K.J.et al. The conformational activation of antithrombin. J Biol Chem. 275:2000;15,377-15,383. a.
19. Huntington J.A., Olson S.T., Fan B., Gettins P.G.W. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding. Biochemistry. 35:1996;8495-8503.
20. Huntington J.A., Read R.J., Carrell R.W. Structure of a serpin-protease complex shows inhibition by deformation. Nature. 407:2000;923-926. b.
21. Ishiguro K., Kojima T., Kadomatsu K.et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest. 106:2000;873-878.
22. Jin L., Abrahams J.P., Skinner R.et al. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA. 94:1997;14,683-14,688.
23. Lawrence D.A., Olson S.T., Muhammad S.et al. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into β-sheet A. J Biol Chem. 275:2000;5839-5844.
24. Le Bonniec B.F., MacGillivray R.T., Esmon C.T. Thrombin Glu-39 restricts the P′3 specificity to nonacidic residues. J Biol Chem. 266:1991;13,796-13,803.
25. Le Bonniec B.F., Myles T., Johnson T.et al. Characterization of the P2′ and P3′ specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry. 35:1996;7114-7122.
26. Marcum J.A., Atha D.H., Fritze L.M.S.et al. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparin sulfate proteoglycan. J Biol Chem. 261:1986;7507-7517.
27. Olson S.T., Björk I., Sheffer R.et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem. 267:1992;12,528-12,538.
28. Olson S.T., Stephens A.W., Hirs C.H.W.et al.: Kinetic characterization of the proteinase binding defect in a reactive site variant of the serpin, antithrombin. Role of the P. 1′(residue in transition-state stabilization of antithrombin-proteinase complex formation. J Biol Chem 270):1995;9717-9724.
29. Owen M.C., Brennan S.O., Lewis J.H., Carrell R.W. Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met to Arg), a fatal bleeding disorder. N Engl J Med. 309:1983;694-698.
30. Owen M.C., George P.M., Lane D.A., Boswell D.R. P1 variant antithrombins Glasgow (393 Arg to His) and Pescara (393 Arg to Pro) have increased heparin affinity and are resistant to catalytic cleavage by elastase. Implications for the heparin activation mechanism. FEBS Lett. 280:1991;216-220.
31. Pike R.N., Potempa J., Skinner R.et al. Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J Biol Chem. 272:1997;19,652-19,655.
32. Rezaie A.R. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa J Biol Chem. 273:1998;16,824-16,827.
33. Silverman G.A., Bird P.I., Carrell R.W.et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. J Biol Chem. 276:2001;33,293-33,296.
34. Skinner R., Abrahams J.-P., Whisstock J.C.et al. The 2.6 Å structure of antithrombin indicates a conformational change at the heparin binding site. J Mol Biol. 266:1997;601-609.
35. Stratikos E., Gettins P.G.W. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 Å and full insertion of the reactive center loop into β-sheet A. Proc Natl Acad Sci USA. 96:1999;4808-4813.
36. Theunissen H.J.M., Dijkema R., Grootenhuis P.D.J.et al. Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site. J Biol Chem. 268:1993;9035-9040.
37. Thunberg L., Bäckström G., Lindahl U. Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res. 100:1982;393-410.
38. Van Boven H.H., Lane D.A. Antithrombin and its inherited deficiency states. Semin Hematol. 34:1997;188-204.
39. Wallace A., Rovelli G., Hofsteenge J., Stone S.R. Effect of heparin on the glia-derived nexin-thrombin interaction. Biochem J. 257:1989;191-196.
40. Wilkens M., Krishnaswamy S. The contribution of factor Xa to exosite-dependent substrate recognition by prothrombinase. J Biol Chem. 277:2002;9366-9374.